Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia Areata is an autoimmune condition often starting before age 20, with varied treatment success and a need for personalized treatment plans.

The Lexington LaserComb helped regrow hair in mice with a condition similar to human hair loss.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Hair grays due to oxidative stress and fewer functioning melanocytes.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

A position effect on the TRPS1 gene causes excessive hair growth in humans and mice.

Zinc can both inhibit and stimulate mouse hair growth, and might help recover hair after chemotherapy.

Both mouse and rat models are effective for testing alopecia areata treatments.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document concludes that mouse models are crucial for studying hair biology and that all mutant mice may have hair growth abnormalities that require detailed analysis to identify.

Estrogens generally inhibit hair growth and improve skin quality, but their exact effects on hair follicles are complex and not fully understood.

New treatments for acne scars are safer and more effective because we understand the causes better.

Cosmetics enhance beauty, fix defects, and intimidate enemies, with varying cultural standards and alternative methods.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

People with late-stage HIV-1 often experience a specific type of hair loss linked to multiple factors, including nutritional issues and immune responses.

Recognizing the different stages of alopecia areata is crucial for accurate diagnosis and treatment.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

Healthy women tend to lose more hair in July and April, and the least in February.

Congenital Triangular Alopecia is a rare, non-scarring hair loss that can be surgically treated in females for cosmetic reasons.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Trichoscopy can effectively tell apart tinea capitis and alopecia areata in children by looking for specific hair shapes.

Skin organoids are a promising new model for studying human skin development and testing treatments.

The model suggests that scalp tension could lead to hair loss, with factors like blood vessel hardening, enlarged oil glands, and poor microcirculation also playing a role. It also hints at a possible link between skull shape and baldness pattern.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Skin aging is caused by stem cell damage and can potentially be delayed with treatments like antioxidants and stem cell therapy.

Genetic research has advanced our understanding of skin diseases, but complex conditions require an integrative approach for deeper insight.